title: AgNORs in breast tumours.
abstract: There is evidence that the quantitative distribution of AgNOR proteins is a proliferation-related parameter that can be used as a prognostic index in tumour pathology. In breast cancer, some authors found a significant prognostic correlation of AgNOR protein quantity, whereas other did not. However, in all the reports dealing with AgNOR area (as opposed to count) this parameter was always turned out to be an independent prognostic indicator. The present study tests the significance of AgNOR proteins in a large series of primary breast carcinomas, exploring the associations between the AgNOR protein amount, as evaluated by image cytometry, and the other well-established prognostic markers commonly considered for breast cancer, along with patients' survival. Our results demonstrated a highly significant association between AgNOR protein quantity and tumour prognosis. Moreover, when the AgNOR area values were entered in multivariate analysis together with the other predictive parameters commonly considered in breast carcinomas, they showed an independent prognostic value together with Ki67-labelling index (LI), N-status and tumour size. Considering node-negative and -positive cases separately, the AgNOR protein area and Ki67-LI both come out as a independent predictors only in the latter group: the short follow-up time of our series (36 months median) could be responsible for this discrepancy.
authors.affiliation: Dipartimento di Scienze Radiologiche e Citoistopatologiche, Università di Bologna, Policlinico S. Orsola, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Ceccarelli
authors.forename: D
authors.initials: D
authors.lastname: Trerè
authors.forename: D
authors.initials: D
authors.lastname: Santini
authors.forename: M
authors.initials: M
authors.lastname: Taffurelli
authors.forename: P
authors.initials: P
authors.lastname: Chieco
authors.forename: M
authors.initials: M
authors.lastname: Derenzini
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry / Q000175:diagnosis* / Q000648:ultrastructure; D002288:Adenocarcinoma, Mucinous / Q000737:chemistry / Q000175:diagnosis / Q000648:ultrastructure; D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000737:chemistry / Q000175:diagnosis* / Q000648:ultrastructure; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry / Q000175:diagnosis / Q000648:ultrastructure; D018275:Carcinoma, Lobular / Q000737:chemistry / Q000175:diagnosis / Q000648:ultrastructure; D005260:Female; D006801:Humans; D019044:Image Cytometry / Q000379:methods; D019394:Ki-67 Antigen / Q000032:analysis; D015999:Multivariate Analysis; D009687:Nuclear Proteins / Q000032:analysis*; D009697:Nucleolus Organizer Region / Q000737:chemistry / Q000648:ultrastructure; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D016622:Silver Staining
chemical_list: D014408:Biomarkers, Tumor; D019394:Ki-67 Antigen; D009687:Nuclear Proteins; D011960:Receptors, Estrogen